|
It's not a question of cost at this point. It's a question of availability of reagents and consumables, materials to make those, and time it takes to ramp up. The supply chain is like a supertanker. At first we didn't have enough test, but that ramped up quickly, then we didn't have enough RNA extraction reagent, now we don't have enough swabs, and soon is the collection media that will be missing. There has been a call for more protective equipement. But as the situation gets worst, beds space, ventilator, and then staff are going to be the bottleneck. If you google you'll find stories of people helping their local hospital by 3D printing parts for for respirators, and swabs. There's nothing cost effective about that, it's not fast, but it gets the job done. If you were to scale that, you would be competing for the same materials than manufacturers using injection molding or plastic dipping are. |
Where are you getting this information from?